Dr. James Rothman

Senior Advisor

Dr. Rothman is an internationally renowned scientist. He was awarded the 2013 Nobel Prize in medicine and has received numerous other honors including the Lasker Basic Research Award. Dr. Rothman is also a biopharmaceutical company founder, life science industry executive, and prestigious academic leader. Dr. Rothman served as chief scientist and executive committee member at GE Healthcare, at the time a$15B unit of General Electric Corporation. Prior to the acquisition of Amersham Biosciences PLC by GE Healthcare, Dr. Rothman served as chief scientist at Amersham. His distinguished academic career includes endowed chairs at Memorial Sloan-Kettering Cancer Center where he served as vice-chair of the Sloan-Kettering Institute; Columbia University’s College of Physicians and Surgeons; and Yale University, where he is currently the Sterling Professor and of Cell Biology and Director of the Nanobiology Institute. He is a member of the National Academy of Sciences and the Academy of Medicine, and a Foreign Member of the Royal Society.

‍

"There is a pattern recognition to be discovered when looking at early-stage companies. What I look for initially, more than anything else, is an original cool scientific idea. Then, you must have an entrepreneur who can communicate that idea with passion, and an idea that can add value in a profound way to a marketplace. It can sound trivial because of course you're looking for passion, an original idea, an unmet need – these are all obvious. But somehow this is where the pattern recognition comes in, spotting this magic combination when you see it."
boards
1Cell.Ai
Alveo
Prellis
connect
news